Stocks · Health care · Biological Products, (No Diagnostic Substances)

Aura Biosciences, Inc.

AURA Clue Score20
United States Fiscal year ends December CIK 0001501796 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Anthony S Gibney
16 Jun 2026
See Remarks
Sell
12,824
$6.42
$82.33K
Matrix Capital Management Company, LP
7 May 2026
10% owner
Sell indirect
6,922,870
$5.64
$39.04M
Conor Kilroy
16 Apr 2026
See Remarks
Sell
11,738
$7.02
$82.40K
los Pinos Elisabet de
17 Feb 2026
See Remarks
Sell
47,648
$5.06
$241.10K
Amy Elazzouzi
17 Feb 2026
Senior Vice President, Finance
Sell
8,549
$5.06
$43.26K
Janet Jill Hopkins
17 Feb 2026
Chief Medical Officer
Sell
20,401
$5.06
$103.23K
Mark Plavsic
17 Feb 2026
Chief Technology Officer
Sell
15,890
$5.05
$80.24K
Conor Kilroy
17 Feb 2026
See Remarks
Sell
12,079
$5.05
$61.00K
los Pinos Elisabet de
20 Jan 2026
See Remarks
Sell
16,928
$4.86
$82.27K
Amy Elazzouzi
20 Jan 2026
Senior Vice President, Finance
Sell
1,581
$4.86
$7.68K
Janet Jill Hopkins
17 Nov 2025
Chief Medical Officer
Sell
17,109
$5.42
$92.73K
los Pinos Elisabet de
29 Oct 2025
See Remarks
Sell
9,049
$6.35
$57.46K
Amy Elazzouzi
29 Oct 2025
Senior Vice President, Finance
Sell
896
$6.35
$5.69K
Mark Plavsic
16 Oct 2025
Chief Technology Officer
Sell
12,169
$6.35
$77.27K
Amy Elazzouzi
18 Aug 2025
Senior Vice President, Finance
Sold after exercise
7,722
$6.70
$51.74K
los Pinos Elisabet de
2 Jun 2025
See Remarks
Exercised, kept
10,948
$5.07
$55.51K
Anthony S Gibney
16 May 2025
See Remarks
Sell
1,519
$5.15
$7.82K
Anthony S Gibney
16 May 2025
See Remarks
Buy
50,000
$4.90
$245.00K
David Michael Johnson
16 May 2025
Director
Buy
20,000
$4.90
$98.00K
Conor Kilroy
16 Apr 2025
See Remarks
Sell
7,162
$5.49
$39.32K
Amy Elazzouzi
16 Apr 2025
Senior Vice President, Finance
Sell
897
$5.49
$4.92K
los Pinos Elisabet de
18 Feb 2025
See Remarks
Sell
20,221
$7.75
$156.80K
Janet Jill Hopkins
18 Feb 2025
Chief Medical Officer
Sell
2,534
$7.75
$19.64K
Amy Elazzouzi
18 Feb 2025
Senior Vice President, Finance
Sell
1,404
$7.75
$10.88K
Mark Plavsic
18 Feb 2025
Chief Technology Officer
Sell
2,151
$7.75
$16.67K
Amy Elazzouzi
21 Jan 2025
Vice President, Finance
Sell
1,001
$7.67
$7.68K
los Pinos Elisabet de
21 Jan 2025
See Remarks
Sell
15,955
$7.67
$122.38K
Janet Jill Hopkins
18 Nov 2024
Chief Medical Officer
Sell
11,822
$9.36
$110.66K
Amy Elazzouzi
29 Oct 2024
Vice President, Finance
Sell
553
$10.74
$5.94K
los Pinos Elisabet de
29 Oct 2024
See Remarks
Sell
9,200
$10.74
$98.79K
los Pinos Elisabet de
18 Oct 2024
See Remarks
Sold after exercise
24,992
$12.04
$300.84K
Julie B Feder
18 Oct 2024
Chief Financial Officer
Sold after exercise
25,131
$12.03
$302.36K
Mark Plavsic
16 Oct 2024
Chief Technology Officer
Sell
7,383
$9.85
$72.72K
los Pinos Elisabet de
27 Sep 2024
See Remarks
Exercised, kept
5,474
$5.76
$31.53K
Julie B Feder
23 Jan 2024
Chief Financial Officer
Sell
6,609
$7.64
$50.52K
los Pinos Elisabet de
23 Jan 2024
See Remarks
Sell
15,853
$7.64
$121.14K
Matrix Capital Management Company, LP
9 Nov 2023
10% owner
Buy indirect
1,560,000
$9.00
$14.04M
David Michael Johnson
8 Nov 2023
Director
Buy indirect
10,000
$7.30
$73.00K
David Michael Johnson
8 Nov 2023
Director
Buy indirect
10,000
$7.30
$73.00K
David Michael Johnson
8 Nov 2023
Director
Buy
9,601
$7.30
$70.09K
David Michael Johnson
7 Nov 2023
Director
Buy indirect
47,000
$7.17
$336.99K
David Michael Johnson
7 Nov 2023
Director
Buy indirect
47,000
$7.17
$336.99K
David Michael Johnson
7 Nov 2023
Director
Buy
76,000
$7.17
$544.92K
Julie B Feder
6 Nov 2023
Chief Financial Officer
Sold after exercise
3,900
$12.07
$47.05K
los Pinos Elisabet de
6 Nov 2023
See Remarks
Sold after exercise
7,449
$12.03
$89.61K
los Pinos Elisabet de
30 Oct 2023
See Remarks
Sell
9,586
$6.83
$65.48K
Julie B Feder
30 Oct 2023
Chief Financial Officer
Sell
3,385
$6.82
$23.09K
David Michael Johnson
4 Oct 2023
Director
Buy
6,566
$8.61
$56.51K
David Michael Johnson
3 Oct 2023
Director
Buy
13,500
$8.27
$111.66K
David Michael Johnson
6 Jan 2023
Director
Buy indirect
904
$10.51
$9.50K
David Michael Johnson
6 Jan 2023
Director
Buy indirect
700
$10.50
$7.35K
David Michael Johnson
5 Jan 2023
Director
Buy indirect
96
$10.00
$960.00
David Michael Johnson
5 Jan 2023
Director
Buy indirect
300
$10.00
$3.00K
David Michael Johnson
28 Dec 2022
Director
Buy indirect
2,000
$9.75
$19.50K
David Michael Johnson
28 Dec 2022
Director
Buy indirect
2,000
$9.75
$19.50K
Matrix Capital Management Company, LP
5 Dec 2022
10% owner
Buy indirect
1,250,000
$12.00
$15.00M
David Michael Johnson
1 Dec 2022
Director
Buy indirect
5,000
$12.37
$61.85K
David Michael Johnson
1 Dec 2022
Director
Buy indirect
5,000
$12.37
$61.85K
Rosch Mark De
31 Oct 2022
Chief Operating Officer
Sell
1,115
$12.46
$13.89K
los Pinos Elisabet de
31 Oct 2022
See Remarks
Sell
5,706
$12.46
$71.08K
Cadmus Rich
31 Oct 2022
See Remarks
Sell
1,672
$12.45
$20.81K
Julie B Feder
31 Oct 2022
Chief Financial Officer
Sell
2,015
$12.45
$25.09K
David Michael Johnson
13 Jun 2022
Director
Buy
20,000
$13.99
$279.80K
David Michael Johnson
13 Jun 2022
Director
Buy indirect
7,000
$13.99
$97.93K
David Michael Johnson
13 Jun 2022
Director
Buy indirect
7,000
$13.99
$97.93K
David Michael Johnson
10 Jun 2022
Director
Buy
10,000
$15.04
$150.40K
David Michael Johnson
10 Jun 2022
Director
Buy indirect
3,000
$15.04
$45.12K
David Michael Johnson
10 Jun 2022
Director
Buy indirect
3,000
$15.04
$45.12K
Matrix Capital Management Company, LP
2 Nov 2021
10% owner
Buy indirect
1,785,000
$14.00
$24.99M
Medicxi Ventures Management (Jersey) Ltd
2 Nov 2021
10% owner
Buy indirect
16,475
$14.00
$230.65K
Medicxi Ventures Management (Jersey) Ltd
2 Nov 2021
10% owner
Buy indirect
693,525
$14.00
$9.71M

What was left out

Form 4 filings counted 112
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 8,755,291
Sales filed before the plan box existed 4
History held since 29 Oct 2021